Cresco Labs enters Florida market by acquiring assets of VidaCann Ltd.
Category: #business  By Mateen Dalal  Date: 2019-03-19
  • share
  • Twitter
  • Facebook
  • LinkedIn

Cresco Labs enters Florida market by acquiring assets of VidaCann Ltd.

The purchase consideration is approx. $120m and would consist of a mixture of cash and Cresco Labs shares

Cresco would be having 21 retail dispensaries and 14 production facilities upon the closing of the transaction

U.S. based leading vertically integrated multistate cannabis operator, Cresco Labs Inc., has recently announced that the company is entering the Florida market. Apparently, this would be executed via signing of a letter agreement for acquiring the assets or ownership interests of VidaCann Ltd., one of the most advanced and largest providers of medical cannabis in Florida, and/ or its affiliated entities.

Sources familiar with the matter informed that the purchase consideration is approx. $120 million and would be consisting of a mixture of cash and Cresco Labs shares, that would be subjected to a 6 to 12 month of lock-up agreement followed by closing. This stock and proportion of cash and final purchase price would be determined and reflected in the definitive agreement.

Reportedly, Cresco Labs would have 21 retail dispensaries and 14 production facilities upon the closing of the transaction, besides having licenses for operating a sum of 51 retail dispensaries across 10 states, such as Florida, Arizona, California, Nevada, Ohio, Pennsylvania, Illinois with Massachusetts, Maryland and New York pending approval.

Charlie Bachtell, Co-founder and Chief Executive of Cresco Labs, mentioned that entering the Florida market is in line with the strategy of the company of entering markets with strong regulatory structures with outsized demand. It is a crucial milestone for Cresco Labs that largely impacts the company’s growth trajectory and would be accretive to its earnings in 2019, he said.

Bachtell added that Florida has witnessed remarkable growth in patient registration since relaunching its cannabis program in 2017 and is among the most significant markets in the nation. The company looks forward towards welcoming all of the 100 VidaCann employees to the family of Cresco Labs.

For the record, Bennett Jones is acting as the Canadian legal advisor, and Canaccord Genuity Corp. as the financial advisor to Cresco Labs.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Microsoft to fix an active security flaw in Internet Explorer
Microsoft to fix an active security flaw in Internet Explorer
By Mateen Dalal

Microsoft, the renowned American tech giant, reportedly verified the presence of a security flaw that is affecting Internet Explorer (IE) and is being used by hackers. The company also said it is working to find a fix for this bug, which would be rel...

Dermtech signs a commercial & medicare advantage coverage agreement
Dermtech signs a commercial & medicare advantage coverage agreement
By Mateen Dalal

DermTech Inc., a San Diego based biotechnology company that is involved in precision dermatology, has recently announced signing a contract with a regional health plan to develop its gene expression based PLA (Pigmented Lesion Assay) for prior detect...

CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
By Mateen Dalal

The merger will bring two therapeutic immune-oncology platforms together Focus shall be placed over Phase 1 and Phase 2 trials of CAR-CIK and CMN-001 respectively U.S.-based bioscience firm CoImmune, Inc., announces partnership with Formula Phar...